Original price was: $ 149.99.Current price is: $ 109.99.
Introduction
Ipamorelin is a selective synthetic pentapeptide growth hormone secretagogue studied extensively in laboratory research involving pituitary GH release regulation, GHS-R1a receptor pharmacology, and endocrine axis selectivity investigation. As a compound of significant scientific interest, Ipamorelin is used by researchers investigating the fundamental mechanisms of selective growth hormone secretagogue receptor activation with minimal influence on other pituitary hormones in controlled experimental models.
What Is Ipamorelin?
Ipamorelin is a selective synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) classified as a growth hormone secretagogue receptor (GHS-R1a) agonist. In research settings, it is examined for its selective stimulation of GH release from the anterior pituitary with a noted minimal influence on cortisol and prolactin secretion compared to other GHS compounds in preclinical models. Scientists study this compound to better understand how selective GHS-R1a activation regulates pulsatile GH release patterns and downstream endocrine signaling in laboratory systems.
Structure and Function
Ipamorelin is a five-amino acid synthetic pentapeptide engineered for selective GHS-R1a receptor binding and stable experimental performance. Its primary research function involves studying selective GH secretion from pituitary cells with a minimal off-target hormone release profile compared to other secretagogue compounds. Researchers also investigate its receptor binding kinetics and downstream signaling specificity, making it relevant to studies in endocrinology, growth hormone physiology, and GHS-R receptor pharmacology research.
Research Applications
Ipamorelin is of interest across several areas of scientific investigation, including:
Pulsatile growth hormone release regulation mechanism studies within endocrine system research models Cellular repair, regeneration, and metabolism effects investigations in various tissue model systems Body composition parameter exploration including lean mass and adipose tissue effects in preclinical study designs Selectivity profile comparative studies versus other GHS compounds to understand receptor binding kinetics and signaling Synergistic effect research examining combined peptide administration in controlled experimental conditions
Research Findings and Scientific Interest
Studies have examined the role of Ipamorelin in selective GHS-R1a receptor activation, with findings supporting its minimal influence on cortisol and prolactin secretion alongside GH stimulation in preclinical models — distinguishing it from less selective growth hormone secretagogues. Research into its receptor selectivity profile and downstream signaling characteristics continues to attract interest from the endocrinology and growth hormone biology research communities. Its pentapeptide structure and defined selectivity profile support precise comparative pharmacology investigations.
Availability and Specifications
Ipamorelin is available in lyophilized powder form at 2mg per vial, supplied as 10 vials per set, for use in controlled laboratory environments by qualified researchers.
This product is intended strictly for laboratory research purposes only. It is not intended for human consumption or for medical, veterinary, or therapeutic use.
Related Products
FAQ
Customer Reviews